WHO backs use of GLP-1 therapies for obesity, warns access will remain limited
The World Health Organisation on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for the condition, which affects more than 1 billion people globally according to the agency. The guidance comes as demand fo
